RIPK1 and Glucose intolerance: In diabetic mice, RIP1 expression is increased in liver, adipose tissue, and muscle, and targeting RIPK1 with a specific inhibitor, necrostatin-1 (Nec-1), prevents insulin resistance and glucose intolerance, independent of its effect on inflammation (Xu et al, 2019).